Delivery Order SPE2DB25D3012-SPE2DB25FWYSQ
Award Date 7/21/25
Potential Completion Date 7/22/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $10,006.04 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on July 21, 2025, with completion expected by July 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. RINVOQ (upadacitinib) is a Janus kinase inhibitor used to treat rheumatoid arthritis and other...
- The Defense Logistics Agency Medical Supply Chain awarded a $147,324.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 45 mg tablets (28-count units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This non-set-aside competitive award represents a child delivery order executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026...
- This delivery order, awarded July 18, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides for the supply of RINVOQ ER 15 mg tablets in a 30-count unit dosage format. The contract represents a firm fixed-price delivery order with a ceiling value of $7,554.64 and an ultimate completion date of July 21, 2025. The award was made on a competitive basis with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform...
- The Defense Logistics Agency awarded a delivery order under an undisclosed contract vehicle to Amerisourcebergen Drug Corporation for $10,804.42 to supply 4561326514 RINVOQ ER 45 MG tablets. Performance will take place in Conshohocken, Pennsylvania from June 23 to June 26, 2023. The firm-fixed-price order is for the delivery of RINVOQ, an oral Janus kinase inhibitor medication used to treat rheumatoid arthritis. As a major provider of pharmaceuticals and medical supplies to the U.S. Department...
- The Defense Logistics Agency awarded a $20,889.30 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RINVOQ ER 15 MG tablets. The order is for 30 units of the medication and will be fulfilled by Amerisourcebergen from its facility in Conshohocken, Pennsylvania by September 25, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for RINVOQ, a prescription medication used to treat rheumatoid arthritis, supports the...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $7,818 to Amerisourcebergen Drug Corporation for RINVOQ ER 45 MG tablets. The order is to provide 28,500 tablets to a Defense Logistics Agency facility located in Conshohocken, Pennsylvania, with performance required between September 15-18, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense globally, this order for RINVOQ, an FDA-approved treatment for...
- The Defense Logistics Agency awarded a delivery order valued at $37,112.83 to AmerisourceBergen Drug Corp for RINVOQ ER 45 mg tablets (28-tablet units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract is being...
- The Defense Logistics Agency awarded a $56,931.76 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RINVOQ ER 15 MG tablets. The order is for 30 units of the medication to be delivered to Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 9, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for Rinvoq, an FDA-approved treatment for rheumatoid arthritis, supports the Defense Logistics Agency's...
- The Defense Logistics Agency awarded a $20,398.62 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RINVOQ ER 45 MG tablets. The order is for 28S of the medication and will be fulfilled from Amerisourcebergen's facility located in Conshohocken, Pennsylvania by August 9, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for RINVOQ, a prescription medication used to treat rheumatoid arthritis, supports the Defense...
- The Defense Logistics Agency awarded a $7,935.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside award represents a pediatric or adult rheumatoid arthritis treatment pharmaceutical, with performance occurring at the vendor's Conshohocken, Pennsylvania location. The delivery order functions as a child contract under AmerisourceBergen's broader...